Skip to main content

Treatment of Acute Lymphoblastic Leukemia in Children

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Treatment of Acute Lymphoblastic Leukemia in Children

Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy

Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease

A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Two-part Phase IIb Trial of Vigil in Ewing's Sarcoma

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF

Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors

A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 156
  • Page 157
  • Page 158
  • Page 159
  • Page 160
  • Page 161
  • Page 162
  • Page 163
  • Page 164
  • …
  • Next page Next
  • Last page Last
Subscribe to